Skip to main content

Mesenchymal Stem Cell and Hematopoietic Stem Cell Transplantation for Vasculitis

  • Chapter
  • First Online:
Stem Cell Therapy for Vascular Diseases
  • 449 Accesses

Abstract

Vasculitis poses a great therapeutic challenge to the treating physician. Steroids remain the mainstay of the treatment and biologics are emerging as popular agents. Similar to other immune-mediated diseases, refractory vasculitis seems to be a suitable candidate for bone marrow and mesenchymal stem cell transplantation. Preliminary data show stem cell-based therapies are feasible and effective in severe, treatment-resistant forms of several types of vasculitis. However, due to the fact that patients are rare, clinical data are sparse. Further prospective studies are needed to confirm these preliminary results. In addition, mostly partial remissions are achieved after stem cell transplantation; thus optimization of the therapeutical regimens is necessary through international cooperation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international Chapel Hill consensus conference nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1–11.

    Article  CAS  Google Scholar 

  2. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med. 1999;341(17):1284–91.

    Article  CAS  Google Scholar 

  3. Barron KS, Shulman ST, Rowley A, et al. Report of the National Institutes of Health workshop on Kawasaki disease. J Rheumatol. 1999;26(1):170–90.

    CAS  PubMed  Google Scholar 

  4. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116(6):488–98.

    Article  CAS  Google Scholar 

  5. Scott DG, Watts RA. Systemic vasculitis: epidemiology, classification and environmental factors. Ann Rheum Dis. 2000;59(3):161–3.

    Article  CAS  Google Scholar 

  6. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(2):315–7.

    Article  CAS  Google Scholar 

  7. Figueroa FE, Carrión F, Villanueva S, Khoury M. Mesenchymal stem cell treatment for autoimmune diseases: a critical review. Biol Res. 2012;45(3):269–77.

    Article  Google Scholar 

  8. Zhao RC, Liao L, Han Q. Mechanisms of and perspectives on the mesenchymal stem cell in immunotherapy. J Lab Clin Med. 2004;143(5):284–91.

    Article  Google Scholar 

  9. Klinker MW, Wei CH. Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models. World J Stem Cells. 2015;7(3):556–67.

    Article  Google Scholar 

  10. Lee HK, Lim SH, Chung IS, et al. Preclinical efficacy and mechanisms of mesenchymal stem cells in animal models of autoimmune diseases. Immune Netw. 2014;14(2):81–8.

    Article  Google Scholar 

  11. Rad F, Ghorbani M, Mohammadi Roushandeh A, Habibi Roudkenar M. Mesenchymal stem cell-based therapy for autoimmune diseases: emerging roles of extracellular vesicles. Mol Biol Rep. 2019;46(1):1533–49.

    Article  CAS  Google Scholar 

  12. Jantunen E, Myllykangas-Luosujärvi R. Stem cell transplantation for treatment of severe autoimmune diseases: current status and future perspectives. Bone Marrow Transplant. 2000;25(4):351–6.

    Article  CAS  Google Scholar 

  13. Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002;360(9341):1197–202.

    Article  Google Scholar 

  14. Ozen S. The spectrum of vasculitis in children. Best Pract Res Clin Rheumatol. 2002;16(3):411–25.

    Article  CAS  Google Scholar 

  15. Chartapisak W, Opastiraku S, Willis NS, Craig JC, Hodson EM. Prevention and treatment of renal disease in Henoch-Schonlein purpura: a systematic review. Arch Dis Child. 2009;94(1):132–7.

    CAS  PubMed  Google Scholar 

  16. Mu K, Zhang J, Gu Y, et al. Cord-derived mesenchymal stem cells therapy for liver cirrhosis in children with refractory Henoch-Schonlein purpura: a case report. Medicine (Baltimore). 2018;97(47):e13287.

    Article  Google Scholar 

  17. Tsukamoto H, Nagafuji K, Horiuchi T, et al. A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease. Ann Rheum Dis. 2006;65(4):508–14.

    Article  CAS  Google Scholar 

  18. Tyndall A, Passweg J, Gratwohl A. Haemopoietic stem cell transplantation in the treatment of severe autoimmune diseases 2000. Ann Rheum Dis. 2001;60(7):702–7.

    Article  CAS  Google Scholar 

  19. Ashihara E, Shimazaki C, Hirata T, et al. Autoimmune thrombocytopenia following peripheral blood stem cell autografting. Bone Marrow Transplant. 1993;12(3):297–9.

    CAS  PubMed  Google Scholar 

  20. Mccrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association[J]. Circulation. 2017;135(17):e927–99.

    Article  Google Scholar 

  21. Eleftheriou D, Levin M, Shingadia D, Tulloh R, Klein NJ, Brogan PA. Management of Kawasaki disease. Arch Dis Child. 2014;99(1):74–83.

    Article  CAS  Google Scholar 

  22. Noguchi S, Saito J, Kudo T, et al. Safety and efficacy of plasma exchange therapy for Kawasaki disease in children in intensive care unit: case series. JA Clin Rep. 2018;4(1):25.

    Article  Google Scholar 

  23. Uchimura R, Ueda T, Fukazawa R, et al. Adipose tissue-derived stem cells suppress coronary arteritis of Kawasaki disease in vivo. Pediatr Int. 2019; https://doi.org/10.1111/ped.14062.

  24. Wedderburn LR, Jeffery R, White H, et al. Autologous stem cell transplantation for paediatric-onset polyarteritis nodosa: changes in autoimmune phenotype in the context of reduced diversity of the T- and B-cell repertoires, and evidence for reversion from the CD45RO(+) to RA(+) phenotype. Rheumatology (Oxford). 2001;40(11):1299–307.

    Article  CAS  Google Scholar 

  25. Maffei S, Renzo MD, Bova G, et al. Takayasu’s arteritis: a review of the literature. Intern Emerg Med. 2006;1(2):105–12.

    Article  Google Scholar 

  26. Tanaka F, Kawakami A, Iwanaga N, et al. Infliximab is effective for Takayasu arteritis refractory to glucocorticoid and methotrexate. Intern Med. 2006;45(2):313–6.

    Article  Google Scholar 

  27. Nakaoka Y, Higuchi K, Arita Y, et al. Tocilizumab for the treatment of patients with refractory takayasu arteritis. Int Heart J. 2013;54(2):405–11.

    Article  CAS  Google Scholar 

  28. Voltarelli JC, Oliveira MC, Stracieri AB, et al. Haematopoietic stem cell transplantation for refractory Takayasu’s arteritis. Rheumatology (Oxford). 2004;43(10):1308–9.

    Article  CAS  Google Scholar 

  29. Zhou Q, Yang D, Ombrello AK, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370:911–20.

    Article  CAS  Google Scholar 

  30. Navon Elkan P, Pierce SB, Segel R, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med. 2014;370(9):921–31.

    Article  Google Scholar 

  31. Nanthapisal S, Murphy C, Omoyinmi E, et al. Deficiency of adenosine deaminase type 2 (DADA2): a description of phenotype and genotype in 15 cases. Arthritis Rheumatol. 2016;68(9):2314–2.

    Article  CAS  Google Scholar 

  32. Van Montfrans J, Zavialov A, Zhou Q. Mutant ADA2 in vasculopathies. N Engl J Med. 2014;371(5):478–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Liao, L., Gu, Y. (2021). Mesenchymal Stem Cell and Hematopoietic Stem Cell Transplantation for Vasculitis. In: Navarro, T.P., Minchillo Lopes, L.L.N., Dardik, A. (eds) Stem Cell Therapy for Vascular Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-56954-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-56954-9_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-56953-2

  • Online ISBN: 978-3-030-56954-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics